{
    "2018-02-23": [
        [
            {
                "time": "2018-03-05",
                "original_text": "The VIX manipulation scandal will be bigger than the LIBOR scandal",
                "features": {
                    "keywords": [
                        "VIX",
                        "manipulation",
                        "scandal",
                        "LIBOR"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-23",
                "original_text": "New Strong Buy Stocks for February 23rd",
                "features": {
                    "keywords": [
                        "Strong Buy",
                        "Stocks"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm",
                "features": {
                    "keywords": [
                        "AZN",
                        "Imfinzi",
                        "FDA",
                        "MRK",
                        "Australian Firm"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-07",
                "original_text": "Here Are Today’s Biotech Movers: Abbvie, Neurocrine and GW Pharmaceuticals",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Movers",
                        "Abbvie",
                        "Neurocrine",
                        "GW Pharmaceuticals"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Performance of Johnson & Johnson’s Remicade and Stelara in 2017",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Remicade",
                        "Stelara",
                        "Performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-08",
                "original_text": "Abbvie's Uterine Fibrosis Candidate Meets Goal in Study",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "Uterine Fibrosis",
                        "Candidate",
                        "Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}